Syngenta Acquires Glyphosate Tolerance Technology For Corn

May 12, 2004, 01:00 ET from Syngenta International AG

    BASEL, Switzerland, May 12 /PRNewswire/ -- Syngenta announced today that
 it has acquired rights to a commercially successful glyphosate tolerance
 technology in corn from Bayer CropScience. The technology, called GA21,
 enables farmers to control weeds in corn with post emergence applications of
 the non-selective herbicide glyphosate. Syngenta will offer the technology in
 NK(R) brand hybrids and through licenses with other seed companies. Financial
 terms of the transaction were not disclosed.
     "This transaction gives Syngenta fast-track entry into an important
 segment of the corn crop protection market", said David Jones, Head of
 Business Development for Syngenta. "This valuable technology further
 strengthens our already broad product portfolio of corn hybrids, traits and
 crop protection products."
     Syngenta is a world-leading agribusiness committed to sustainable
 agriculture through innovative research and technology. The company is a
 leader in crop protection, and ranks third in the high-value commercial seeds
 market. Sales in 2003 were approximately $6.6 billion. Syngenta employs some
 19,000 people in over 90 countries. Syngenta is listed on the Swiss stock
 exchange (SYNN) and in New York (SYT). Further information is available at
     Analyst/Investor Enquiries:
     Jonathan Seabrook (Switzerland), +41 61 323 7502
     Jennifer Gough (Switzerland), +41 61 323 5059
     Rhonda Chiger (USA), +1 (917) 322 2569
     Media Enquiries: Markus Payer (Switzerland), +41 61 323 2323
     Sarah Hull (USA), +1 (202) 347 8348
     Cautionary Statement Regarding Forward-Looking Statements
     This document contains forward-looking statements, which can be
 identified by terminology such as 'expect', 'would', 'will', 'potential',
 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar
 expressions. Such statements may be subject to risks and uncertainties that
 could cause the actual results to differ materially from these statements. We
 refer you to Syngenta's publicly available filings with the U.S. Securities
 and Exchange Commission for information about these and other risks and
 uncertainties. Syngenta assumes no obligation to update forward-looking
 statements to reflect actual results, changed assumptions or other factors.
 This document does not constitute, or form part of, any offer or invitation
 to sell or issue, or any solicitation of any offer, to purchase or subscribe
 for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form
 the basis of, or be relied on in connection with, any contract therefore.

SOURCE Syngenta International AG